Mitobridge, created in 2011 (United States), from 67 sister brands and 17477 competing brands. Mitobridge is owned by Astellas Pharma, listed on the stock exchange of Francfort Its International Securities Identification Number (ISIN) is JP3942400007. Mitobridge is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
Astellas Pharma
(Mitobridge)
over 5 years*
EUR 6.20